New trial aims to customize breast cancer radiation to cut harmful side effects
NCT ID NCT06382818
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether personalizing the dose and schedule of radiation therapy after breast cancer surgery can reduce long-term side effects like scarring (fibrosis) and radiation-induced cancers, while still preventing the cancer from coming back. The trial will enroll 854 women with invasive breast cancer who have had surgery. Doctors will choose from several standard radiation schedules based on each patient's risk of recurrence and side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Radiotherapy (IMRT) with different dosing schedules
What this could lead to
If successful, this could lead to fewer long-term side effects like fibrosis and sarcoma, while still effectively controlling breast cancer recurrence.
What could go wrong
This is a non-randomized study, so results may be less definitive. The personalized approach may not reduce side effects as hoped, and long-term follow-up is needed to confirm safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut Du Cancer de Montpellier
RECRUITINGMontpellier, France
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••